Association of APOB and LIPC polymorphisms with type 2 diabetes in Chinese Han population

Abstract Background Apolipoprotein B (APOB), and hepatic lipase (LIPC) genes have been shown to play a key role in lipid metabolism in type 2 diabetes (T2D). This study aimed to investigate the association of the three polymorphisms (rs679899 in APOB and rs6078 and rs6083 in LIPC) with T2D and related clinical quantitative traits. Methods We conducted a case-control study in Chinese Han population, with a total of 929 T2D patients and 1044 healthy subjects in Chinese Han population. Polymorphisms were genotyped by MassARRAY Genotyping System. Results The risk allele G of the polymorphism rs679899 was related to T2D (odds ratio (OR): 1.207, 95% confidence interval (CL): 1.006–1.448, P  = 0.043) and the polymorphism rs679899 was associated with glutamyl transpeptidase (GGT) levels ( P  = 0.001). We also showed that the polymorphism rs6083 was associated with cholesterol (CHOL) levels ( P  = 0.012), triglyceride (TG) levels ( P  = 0.040), and low-density lipoprotein cholesterol (LDL) levels ( P  = 0.033). No significant difference in genotypic frequencies of rs6078 and rs6083 was observed between T2D patients and controls. Conclusion This study suggests that the APOB polymorphism rs679899 is associated with type 2 diabetes and GGT levels, while the LIPC polymorphism rs6083 may influence CHOL, TG, and LDL levels in Chinese Han population.